Skip to main content

Peer Review reports

From: Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial

Original Submission
10 Mar 2017 Submitted Original manuscript
23 Sep 2017 Author responded Author comments - Geoff Bellingan
Resubmission - Version 2
23 Sep 2017 Submitted Manuscript version 2
4 Oct 2017 Editorially accepted
13 Nov 2017 Article published 10.1186/s13063-017-2234-7

You can find further information about peer review here.

Back to article page